Involvement of bone morphogenetic protein activity in somatostatin actions on ovarian steroidogenesis

[1]  F. Otsuka,et al.  Regulatory role of kit ligand–c-kit interaction and oocyte factors in steroidogenesis by rat granulosa cells , 2012, Molecular and Cellular Endocrinology.

[2]  F. Otsuka,et al.  BMP action in the pituitary: Its possible role in modulating somatostatin sensitivity in pituitary tumor cells , 2012, Molecular and Cellular Endocrinology.

[3]  Xiao-yan Liang,et al.  Abnormal expression of growth differentiation factor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome. , 2011, Fertility and sterility.

[4]  F. Otsuka,et al.  A novel antagonistic effect of the bone morphogenetic protein system on prolactin actions in regulating steroidogenesis by granulosa cells. , 2010, Endocrinology.

[5]  Ping Liu,et al.  Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome. , 2010, Fertility and sterility.

[6]  F. Otsuka,et al.  Effects of bone morphogenetic protein (BMP) on adrenocorticotropin production by pituitary corticotrope cells: involvement of up-regulation of BMP receptor signaling by somatostatin analogs. , 2010, Endocrinology.

[7]  M. Stridsberg,et al.  Kit ligand and the somatostatin receptor antagonist, BIM-23627, stimulate in vitro resting follicle growth in the neonatal mouse ovary. , 2010, Endocrinology.

[8]  V. Milošević,et al.  Somatostatin-14 influences pituitary–ovarian axis in peripubertal rats , 2008, Histochemistry and Cell Biology.

[9]  H. Schmid.  Pasireotide (SOM230): Development, mechanism of action and potential applications , 2008, Molecular and Cellular Endocrinology.

[10]  F. Otsuka,et al.  Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells. , 2008, The Journal of endocrinology.

[11]  F. Otsuka,et al.  Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells. , 2007, The Journal of endocrinology.

[12]  Shweta Sharma,et al.  Essential role of the oocyte in estrogen amplification of follicle-stimulating hormone signaling in granulosa cells. , 2005, Endocrinology.

[13]  U. Pagotto,et al.  Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[14]  F. Otsuka,et al.  The bone morphogenetic protein system in mammalian reproduction. , 2004, Endocrine reviews.

[15]  F. Otsuka,et al.  Molecular Basis of Bone Morphogenetic Protein-15 Signaling in Granulosa Cells* , 2003, The Journal of Biological Chemistry.

[16]  P. Kelly,et al.  Growth hormone is required for ovarian follicular growth. , 2002, Endocrinology.

[17]  Martin M. Matzuk,et al.  Intercellular Communication in the Mammalian Ovary: Oocytes Carry the Conversation , 2002, Science.

[18]  F. Otsuka,et al.  A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: Its role in regulating granulosa cell mitosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Robertson,et al.  Recruitment and development of the follicle; the roles of the transforming growth factor-β superfamily , 2002, Molecular and Cellular Endocrinology.

[20]  G. Meno-Tetang,et al.  SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. , 2002, European journal of endocrinology.

[21]  E. Baracat,et al.  Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[22]  J. Eppig,et al.  Oocyte control of ovarian follicular development and function in mammals. , 2001, Reproduction.

[23]  V. Milošević,et al.  Effects of Multiple Somatostatin Treatment on rat Gonadotrophic Cells and Ovaries , 2001, The Histochemical Journal.

[24]  K. Miyazono,et al.  Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. , 2001, Journal of cell science.

[25]  V. de Leo,et al.  Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia. , 1999, Human reproduction.

[26]  K. Miyazono,et al.  Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. , 1999, Journal of cell science.

[27]  W. Meyerhof,et al.  Cloning, Expression, Pharmacology and Tissue Distribution of the Mouse Somatostatin Receptor Subtype 5 , 1998, Journal of neuroendocrinology.

[28]  David F. Albertini,et al.  Growth differentiation factor-9 is required during early ovarian folliculogenesis , 1996, Nature.

[29]  J. Huber,et al.  Successful ovulation induction by sandostatin‐therapy of polycystic ovarian disease , 1996, Acta obstetricia et gynecologica Scandinavica.

[30]  A. Lanzone,et al.  Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. , 1995, Fertility and sterility.

[31]  S. Noji,et al.  Identification of a Human Type II Receptor for Bone Morphogenetic Protein-4 That Forms Differential Heteromeric Complexes with Bone Morphogenetic Protein Type I Receptors (*) , 1995, The Journal of Biological Chemistry.

[32]  K. Miyazono,et al.  Cloning and characterization of a human type II receptor for bone morphogenetic proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Lanzone,et al.  Endocrinology: Somatostatin action on rat ovarian steroidogenesis , 1995 .

[34]  J. Smith,et al.  Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects , 1995, The Journal of cell biology.

[35]  J. Massagué,et al.  Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.

[36]  N. Holst,et al.  Somatostatin in physiological concentrations inhibits basal and enhances luteinizing hormone-stimulated progesterone release from human granulosa-luteal cells. , 1995, Human reproduction.

[37]  D. Riddle,et al.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. , 1994, The Journal of biological chemistry.

[38]  A. Duleba,et al.  Sandostatin has no direct effect on ovarian steroidogenesis in vitro. , 1993, Human reproduction.

[39]  P. Hardiman,et al.  Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome. , 1992, Metabolism: clinical and experimental.

[40]  D. Kerr,et al.  Inhibitory action of somatostatin-14 on hormone-stimulated cyclic adenosine monophosphate induction in porcine granulosa and luteal cells. , 1992, The Journal of endocrinology.

[41]  P. Franchimont,et al.  Immunoreactive somatostatin in the rat ovary. , 1992, Acta endocrinologica.

[42]  D. Kunze,et al.  Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta cell. , 1991, The Journal of biological chemistry.

[43]  J. Nešić,et al.  Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome , 1990, The Lancet.

[44]  N. Ling,et al.  Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone , 1973, Science.

[45]  F. Otsuka,et al.  Mutual regulation of growth hormone and bone morphogenetic protein system in steroidogenesis by rat granulosa cells. , 2012, Endocrinology.

[46]  S. Harvey,et al.  Growth hormone: roles in female reproduction. , 2001, The Journal of endocrinology.

[47]  P. Illingworth,et al.  The somatostatin analogue, octreotide, modifies both steroidogenesis and IGFBP-1 secretion in human luteinizing granulosa cells. , 1998, Human reproduction.

[48]  A. Lanzone,et al.  Somatostatin action on rat ovarian steroidogenesis. , 1995, Human reproduction.